Search results for “Coronary artery insufficiency” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 60 patents, we discovered top 27 key players by total patent application. Fujisawa Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Roussel UCLAF are dominant in this area. They take 36.67% of the total patent filing.
Fujisawa Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 9
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 7
Roussel UCLAF
undefined undefined
Patent: 6
Daicel Corp.
Chiba-ken, Japan
Patent: 5
Beiersdorf AG
Hamburg, Germany
Patent: 5
Warner-Lambert Co.
New Jersey, United States
Patent: 3
Sandoz AG
Switzerland
Patent: 3
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Lazio, Italy
Patent: 2
Ventrus Biosciences, Inc.
New York, United States
Patent: 2
Merrell Dow Pharmaceuticals, Inc.
United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Korea Institute of Science & Technology
South Korea
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: